Characterization of Nme5-Like Gene/Protein from the Red Alga Chondrus Crispus by Perina, Dragutin et al.
marine drugs 
Article
Characterization of Nme5-Like Gene/Protein from the
Red Alga Chondrus Crispus
Dragutin Perina 1,2,*,†, Marina Korolija 3,4,†, Andreja Mikocˇ 1, Mirna Halasz 1,
Maja Herak Bosnar 3 and Helena C´etkovic´ 1,*
1 Division of Molecular Biology, Ruđer Boškovic´ Institute, 10000 Zagreb, Croatia; mikoc@irb.hr (A.M.);
mimesek@irb.hr (M.H.)
2 Ministry of Health of the Republic of Croatia, 10000 Zagreb, Croatia
3 Division of Molecular Medicine, Ruđer Boškovic´ Institute, 10000 Zagreb, Croatia; mkorolija@mup.hr (M.K.);
mherak@irb.hr (M.H.B.)
4 Forensic Science Centre “Ivan Vucˇetic´”, 10000 Zagreb, Croatia
* Correspondence: Dragutin.Perina@miz.hr (D.P.); cetkovic@irb.hr (H.C´.);
Tel.: +385-1469-8453 (D.P.); +385-1456-1115 (H.C´.)
† These authors contributed equally to this work.
Received: 28 November 2019; Accepted: 19 December 2019; Published: 21 December 2019 
Abstract: The Nme gene/protein family of nucleoside diphosphate kinases (NDPK) was originally
named after its member Nm23-H1/Nme1, the first identified metastasis suppressor. Human Nme
proteins are divided in two groups. They all possess nucleoside diphosphate kinase domain (NDK).
Group I (Nme1-Nme4) display a single type NDK domain, whereas Group II (Nme5-Nme9) display
a single or several different NDK domains, associated or not associated with extra-domains. Data
strongly suggest that, unlike Group I, none of the members of Group II display measurable NDPK
activity, although some of them autophosphorylate. The multimeric form is required for the NDPK
activity. Group I proteins are known to multimerize, while there are no data on the multimerization of
Group II proteins. The Group II ancestral type protein was shown to be conserved in several species
from three eukaryotic supergroups. Here, we analysed the Nme protein from an early branching
eukaryotic lineage, the red alga Chondrus crispus. We show that the ancestral type protein, unlike
its human homologue, was fully functional multimeric NDPK with high affinity to various types of
DNA and dispersed localization throughout the eukaryotic cell. Its overexpression inhibits both cell
proliferation and the anchorage-independent growth of cells in soft agar but fails to deregulate cell
apoptosis. We conclude that the ancestral gene has changed during eukaryotic evolution, possibly in
correlation with the protein function.
Keywords: Nme gene/protein family; Nme5; red alga; Chondrus crispus; eukaryotic evolution;
Nme evolution
1. Introduction
The Nme/Nm23/NDPK is a gene/protein family of nucleoside diphosphate kinases (NDPK),
enzymes that transfer the terminal phosphate group from (d)NTP (mainly ATP) to any (d)NDP
to produce (d)NTPs. In the late eighties it was discovered that one of the family members,
Nm23-H1/Nme1/NDPK A, suppresses metastasis formation and was, therefore, identified as the
first metastasis suppressor gene/protein [1]. To date, ten different Nme genes have been identified
in humans. Nme1 and Nme2 are the most studied representatives due to their involvement in
cancer progression and metastasis. Nme proteins have been divided into two groups based on their
phylogenetic characteristics, presence of protein domains and exon/intron structure [2]. Group I and
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Group II constitute human Nme1-Nme4 and Nme5-Nme9 proteins, respectively. All Nme enzymes
possess at least one nucleoside diphosphate kinase (NDK) domain. There is a single histidine residue
involved in the catalytic mechanism, conserved in all known active NDPK enzymes. Active NDK
domain acts via a ping-pong mechanism, in which the phosphorylation of the histidine residue
occurs by transfer of the terminal phosphate group from (d)NTP. These phosphoenzymes can than
transfer the phosphate group to any (d)NDP to produce (d)NTP. Group I proteins display a single
type NDK domain, whereas Group II proteins display a single or several NDK domains of different
types, sometimes accompanied by extra-domains. The Nme10 protein has passed through a separate
evolutionary history since it seems evident that its NDK domain was inserted relatively recently and,
therefore, cannot be classified in either of the two groups [2]. Interestingly, it seems that the basic
function of NDPKs to form NTPs and dNTPs is only inherent to Group I members [3]. To date none of
the tested Group II Nme family members were able to transfer terminal phosphate group from (d)NTP
to (d)NDP, with a potential exception of Nme6 [4]. At least one of the representatives of Group I proteins
is present in all three domains of life. In eukaryotes, members of the Group I proteins are enzymatically
active in their hexameric form. The Group I proteins show different cellular localization. Nme1/Nme2
are localized in the cytosol and in the nucleus, Nme4 is exclusively mitochondrial, while Nme3 is
considered to be both cytoplasmic and mitochondrial [5]. Interestingly, the Nme genes/proteins have
several additional biochemical roles. It has been suggested that they may function as transcription
regulators [6], protein kinases [7], and DNases [8]. They also possess diverse biological roles in the
cell, including proliferation [9,10], development [11,12], differentiation [13,14], ciliary functions [15],
endocytosis and membrane remodeling [16,17], actin-based cellular remodeling [18], apoptosis [8],
cell–cell communication [19], and cell adhesion [20,21]. In spite of extensive scientific research in this
field for more than two decades, the mechanisms by which the members of the Nme protein family
execute their biological functions are still not elucidated.
In contrast to Group I members, the accumulating data suggest that none of the Group II
members display measurable NDPK activities [3,22–24], even though some of them are able to
autophosphorylate [3,23]. The multimeric forms of Group II members have not yet been determined.
Some features like the three amino acid insertion in the Kpn-loop (named after the “Killer of prune”
mutation of the Drosophila Awd NDP kinase) present in all human Group II members, indicate the lack
of stability of the multimeric structure potentially resulting in defective catalytic activity [24]. Although
little is known about the Group II members’ biology it seems that they might have highly divergent
functions. Nme5 has been found to be most prominently expressed in human testes. It localizes
within axonemal microtubules of spermatid and spermatozoan flagella, suggesting its involvement
in sperm motility [24,25]. Nme5 was found to be strictly associated with active spermatogenesis in
both mouse and lizard [26]. Additionally, expression of Nme5 in mice increased the cellular levels
of GPX-5 (glutathione peroxidase-5), which suggests its critical role in eliminating reactive oxygen
species during spermatogenesis [27].
Comprehensive proteomic analysis of isolated human ciliary axonemes revealed that Nme5 is
also present in somatic airway epithelia cells, together with Nme7 and Nme9 [28]. Furthermore, Nme5
has been identified as a contributor of innate resistance to gemcitabine [29,30]. It has, also, been shown
that simvastatin treatment of human prostate cancer cell line (PC3) resulted in reduced protein levels
of Nme5 [31]. Expression analyses of 23 purine metabolism genes in Alzheimer’s showed deregulation
at the mRNA level of 10 genes, including Nme1, Nme3, Nme5, Nme7, and adenylate kinase 5 (AK5 [32]).
Vertebrate Nme5 possesses a C-terminal Dpy-30 domain of generally unknown function. In
Chlamydomonas reinhardtii, this domain and its flanking sequence mediate the assembly and modulation
of flagellar radial spoke complexes [33]. In Caenorhabditis elegans the DPY-30 protein is essential for
dosage compensation in early embryogenesis, while in males (X0) it is required for developmental
processes such as coordinated movement, normal body size, correct tail morphology and mating
behavior [34]. In mammals, this Dpy-30 is involved in the histone H3K4 methylation and cell fate
specification of embryonic stem cells [35].
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The human Nme6 was reported independently by two groups in 1999 [36]. Compared to Nme1
and Nme2, Nme6 has additional residues on the N and C termini and an insertion in the Kpn-loop. The
fusion protein with a GST tag showed some kinase activity, although lower compared to human Nme1
or Nme2 [4]. Our results on Nme6-like protein in sponges suggest that the function of Nme6 gene
has probably changed during metazoan evolution in correlation with the structure of the protein [22].
Recent analyses of melanoma driver genes revealed that Nme6 has a significant enrichment of somatic
mutations rate [37]. Further, it has been shown that both Nme6 and Nme7 are important in embryonic
stem cell renewal [38].
The most intriguing result considering Group II members came up upon the discovery that
recombinant human Nme7 induces a stable, naïve-like state in human embryonic stem cells and
induces pluripotent stem cells [39]. Nme7−/− mice developed situs inversus and hydrocephalus, which
indicates a role of Nme7 in biogenesis or a function in motile cilia [40]. Normal male fertility and the
absence of rhinitis/sinusitis observed in Nme7−/− mice indicates the importance of Nme7 in biogenesis
of ependymal or embryonic node cilia, rather than the role in respiratory epithelium and spermatozoa
cilia/flagella [40]. In vitro co-sedimentation assays using recombinant proteins showed that both mouse
and Chlamydomonas Nme7 directly bind to microtubules [41], suggesting its ancient function that might
be universal for all eukaryotes. Human Nme7 contains a DM10 domain of unknown function followed
by two NDK domains of which only the first one is able to autophosphorylate [23]. An identical
fluorescence pattern of both DM10 alone and the full length Nme7 (TcNDPK2) GFP-fused products
were detected linked to the cytoskeleton and flagellum of Trypanosoma cruzi, which gives the first
insight into the role of the DM10 domains in Nme enzymes [42].
Human Nme8 is an ortholog of the sea urchin IC1 that encodes a component of sperm outer
dynein arms, and is implicated in primary ciliary dyskinesia, left–right asymmetry randomization,
and male infertility [43].
Nme9 gene displays a similar exon/intron structure as Nme8, and therefore it seems likely that Nme9
originates from an incompletely translocated duplication of Nme8 [2]. Both proteins possess thioredoxin
domain at the N-terminus. Nme8 is distributed in human sperm [44], where it is probably required
during the final stages of sperm tail maturation [45]. On the other hand, Nme9 is a microtubule-binding
protein expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and
axoneme [46]. Recently, the association between Nme8 locus polymorphism and Alzheimer’s disease
has been demonstrated [47,48].
Our comprehensive analyses of the Nme family in eukaryotes revealed conservancy of the
Group II ancestral type proteins in several species from three eukaryotic supergroups. We analyzed
Nme proteins from early branching eukaryotic lineage. The red algae (Rhodophyta) are one of the
oldest groups of eukaryotic algae formed during the primary endosymbiosis event which enabled the
emergence of the first photosynthetic eukaryote [49]. The red macroalgal fossil, 1.2 billion years old,
provides the oldest evidence of a multicellular, sexually reproducing eukaryote [50]. The genome of
Chondrus crispus, Irish moss, has been sequenced, which was a prerequisite for the positioning of red
algae as excellent model organisms for understanding Nme evolution [51]. Our analyses revealed that
the ancestral type of Nme5-like protein, in contrast to the human homologue, was a fully functional
multimeric NDP kinase. This three-domain protein shows high affinity to various types of DNA and
displays a dispersed localization throughout the eukaryotic cell. Simple bioassays revealed that cells
overexpressing this enzyme exhibit inhibition of proliferation and anchorage independent growth in
soft agar but show no influence on apoptosis. We concluded that the structure of the ancestral gene
has changed significantly during eukaryotic evolution in correlation with the protein function.
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2. Results
2.1. Nme Family in Eukaryotes
The increasing number of sequenced eukaryotic genomes reveals that the Nme superfamily
distribution is wider than previously documented. We analyzed the distribution of Nme proteins in all
six major eukaryotic supergroups: Opisthokonta, Amoebozoa, Plantae, Excavata, Chromalveolata, and
Rhizaria. We found Nme homologues from both Group I and Group II in the representatives of all
major eukaryotic supergroups (Table 1). Broader analyses of Nme enzymes, revealed that 1448 Nme
proteins are present in 398 eukaryotic species across all six eukaryotic supergroups. In all these species,
37 types of Nme enzymes were found. The majority of these proteins possess the same combination of
domains present in the human Nme homologues, but there are also many additional distinct domains,
suggesting novel connections between the Nme family and different cellular processes.
In representatives from all eukaryotic supergroups analyzed, more than one Group I Nme gene
was found. It was previously proposed that duplications of Group I Nme genes occurred independently
and frequently in metazoan evolution. However, the evolutionary relations were generally not well
resolved [2,53–55]. As in our earlier studies, phylogenetic analyses of Group I members (data not
shown) do not produce a well-supported tree, and therefore we can only speculate on evolutionary
relations between duplicated Nme Group I genes present in distant eukaryotic supergroups. Recent
human Nme1-4 genes group together, and are generated by duplication events that occurred in the
vertebrate lineage [2,53]. On the contrary, Group II members seem to have emerged earlier in the
eukaryotic evolution. It has been proposed that Nme5, Nme6, and Nme7 were most likely present in
the eukaryote ancestor [55]. Our phylogenetic analyses, however, show that Nme6 probably arose
in the Unikonts lineage (Figure 1A). Nme6-like gene is present in Apusozoa representative who is
presumably the closest relative of Opisthokonts, and in Amoeboza representatives (Table 1). Nme6-like
gene seemingly arose by the duplication of Nme5-like in the ancestor of Unikonts, probably before
the separation of Amoebozoa (Figure 1A). It was proposed that -Nme8 is a choanoflagellate/metazoan
innovation [55]. We found Nme8-like genes also in Fungi (Table 1). Nme8-like appeared earlier in
Unikont evolution than previously suggested, probably in the ancestor of all Opisthokonts, after the
separation of Apusozoa. Nme5-like and Nme7-like seem to be widely distributed throughout eukaryotic
supergroups which indicates that the ancestor of all eukaryotes probably had both genes. The only
exception is the secondary loss within Amoebozoa lineage, a supergroup without any sequenced
representative, containing neither Nme5-like nor Nme7-like. In the majority of eukaryotes analyzed
Nme7-like protein possesses the same domain structure as its human homologue, which indicates that
the eukaryotic ancestor probably possessed Nme7-like gene with an identical domain organization
structure. On the contrary, the distribution of Nme5-like revealed that the eukaryotic ancestor probably
possessed a Nme5-like domain organization dissimilar to the human homologue. Basal representatives
from three eukaryotic supergroups also possess an adenylate kinase (ADK) domain present at the
C-terminal end of Nme5-like (Table 1). Adenylate kinases are phosphotransferase enzymes present
in all three domains of life and they are a part of the cellular machinery responsible for nucleotide
synthesis. So far, nine different adenylate kinase isoenzymes have been identified and characterized in
human. Nme5-like from red algae C. crispus (Nme5-likeCc) possesses an ADK domain that groups
together with human AK1/AK5 (Figure 1B). It is comprised of well conserved elements essential for the
phosphotransferase activity: the glycine rich region (P-loop), (d)NMP binding site, and LID domain,
which is responsible for the substrate ((d)NTP or (d)NDP) binding (Figure 1C).
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Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. Numbers indicate amino acids. Proteins are represented in a scale 1:10 (1 mm =
10 amino acids). Protein domains have been indicated with colored boxes and each protein has been searched against SMART (Simple Modular Architecture Research
Tool)/Pfam databases. Abbreviations of domain names are retrieved from SMART/Pfam databases and indicated in the figure. Shortened names include: NDK,
nucleoside diphosphate kinase; ADK, adenylate kinase; Dpy-30, domain found in the Dpy-30 proteins; DM10, uncharacterized domain; IQ, calmodulin-binding motif;
TM, transmembrane region; Domain which is not retrieved from SMART/Pfam database: MLS, mitochondrial localization signal according to [52].
Eukaryotic
Supergroup
Organism Nme Schematic Domain Presentation
Group I Group II
Unikonts
Opistokonts Homo sapiens
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Research Tool )/Pfam databases. Abbreviations of domain names are retrieved from SMART/Pfam databases and indicated in the figure. Shortened names include: 
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binding motif; TM, transme brane region; Domain which is not retrieved from SMART/Pfam database: MLS, mitochondrial localization signal according to [52]. 
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Table 1. Schematic architecture of Nme pro ins present in eukaryotic representatives. Number  i dicate amino acids. Pro ins are represented i  a scal  1:10 (1 
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Re earch Tool )/Pfa  databases. Abbreviations of do ain names are retrieved from SMART/Pfam databases nd indicated i  the figure. Shortened names include: 
NDK, nucle side diphosph t  kinase; ADK, adenylat  ki se; Dpy-30, domain found in the Dpy-30 proteins; DM10, uncharacterized domain; IQ, calmodulin-
b ding motif; TM, transme brane r gion; Domain which s ot r trieve  from SMART/Pfam database: LS, mit chondrial localiza ion signal according t  [52]. 
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Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. Numbers indicate amino acids. Proteins are represented in a scale 1:10 (1 
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binding mot f; TM, transmembrane r gion; Domain which is not retrieve  from SMART/Pfam database: MLS, mito ondrial localization signal cc rding t  [52]. 
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mm = 0 ino acids). Protein d mains have b en ind cated with colored b xes and each protein has en search d gainst SMART (Simple Mo ular Architecture 
Research Tool )/Pfam databases. Abbrevi tio  of d mai na es are re rieved f om SMART/Pfam database and indic ted in th  figure. Short ned nam s i clude: 
NDK, nucle side diphosph t  kinase; ADK, adenylate ki ; Dpy-30, domain f und in th  Dpy-30 proteins; DM10, u haracteriz d d main; IQ, calmod lin-
binding ot f; TM, ransmemb a  r gi ; omain which is not retri ve  f m SMART/Pfam database: MLS, mitochondrial local zation signal accordi g t  [52]. 
 
Euk ryotic 
Supergroup Organism 
Nm  Schematic Do in Pres t tion 
Group I Group II 
U
n i
k o
n t
s  
Opistokonts 
Homo sapiens 
 
 
Spizellomyces punctatu
  
Apusozoa Theca onas trahens 
 
 
Amoebozoa Dictyostelium purpureum 
 
 
B i
k o
n t
s  
Rhizaria Bigelowiella natans 
 
 
Chromalveolata Phytophthora sojae 
  
177N KD
187N KDMLS
N KD 152
N KD 169
Nme1
e2
Nme3
Nme4
212
376
588
194
D yp -30N KD
N KD N KDM10
N KD N KDN KDThior doxin
N K
Thioredoxin N KD 342
Nme5
6
N e7
N e8
9
B
NmeGp1SpA N KD 150
N KD 185
1423N KDThioredoxin
D M10 N KD N KD 382
N KD D yp -30 199Nme5-like
7-lik
e8 ke N KD N KD N KD N KD N KD
154N KD
231N KD
Nm Gp1TtA
B
N e5-like
N KDM10 ND 427
D yp -30N KD
N KD
1316
1836
7 li
152N KDNmeGp1DpA
221N KDB
153N KDNme6-like
145N KD
157N KD
NmeGp1BnA
312
N KD
N KD
234
B
C
D
Nme -like ADKN KD D yp -30 556
222N KDTM
N KD 151NmeGp1PsA
B
1476
D M10 N KD N KD 349
N KDN KD D yp -30 ADKADK
7-li
Nme5-likeChromalveolata Phytophthora sojae
Mar. Drugs 2020, 18, x  5 of 23 
 
Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. Numbers indicate amino acids. Proteins are represented in a scale 1:10 (1 
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Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. Numbers indicate amino acids. Pro eins are repr sented in a scale 1:10 (1 mm =
10 amino acids). Protein domains have been indicat d with colored boxes and each protein has been searched against SMART (Simple Modular Architecture Research
To l)/Pfam databases. Abbreviations of domain names are retrieved from SMART/Pfam databases and indicated in the figure. Shortened names include: NDK,
nucleoside diphosphate kinase; ADK, adenylate k nase; Dpy-30, domain found in the Dpy-30 proteins; M10, uncharacterized domain; IQ, calmodulin-binding motif;
TM, transmembrane region; Domain which is not retrieved from SMART/Pfam database: MLS, mitochondria localization signal accordi g to [52].
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R search Tool )/Pfam databases. Abbreviations of domain names are retrieved from SMART/Pfam databases and indicated in t e figure. Shortened names include: 
NDK, nucleoside diphosphat  kinase; ADK, adenylate kinase; Dpy-30, domain found in the Dpy-30 protei s; DM10, uncharacterized domain; IQ, calmodulin-
binding motif; TM, transme brane region; o ain which s ot retrieved from SMART/Pfam database: MLS, mitochondrial localiza ion signal according to [52]. 
 
Eukaryotic 
Supergroup Organism 
Nme Sche atic Domain Presentation 
Group I Group II 
U
n i
k o
n t
s  
Opistokonts 
Homo sapiens 
 
 
Spizellomyces punctatus 
  
Apusozoa Thecamona  trahens 
 
 
Amoebozoa Dictyostelium purpureum 
 
 
B i
k o
n t
s  
Rhizaria Bigelowiella natans 
 
 
Chromalveolata Phytophthora s j e 
  
177N KD
187N KDMLS
N KD 152
N KD 169
Nme1
Nme2
Nme3
Nme4
212
376
588
194
D yp -30N KD
N KD N KDDM10
N KD N KDN KDThioredoxin
N KD
Thioredoxin N KD 342
Nme5
Nme6
Nme7
Nme8
Nme9
NmeGp SpB
NmeGp1SpA N KD 150
N KD 185
1423N KDThioredoxin
D M10 N KD N KD 382
N KD D yp -30 199Nme5-like
Nme7-like
Nme8-like N KD N KD N KD N KD N KD
154N KD
231N KD
NmeGp1TtA
NmeGp1TtB
Nme5-like
N KDD M10 N KD 427
D yp -30N KD
N KD
1316
183Nme6-like
Nme7-like
152N KDNmeGp1DpA
221KDNmeGp1DpB
153N KNme6-like
145N KD
157N KD
NmeGp1BnA
312
N KD
N KD
234
NmeGp1BnB
NmeGp1BnC
NmeGp1BnD
Nme5-like ADKN KD D yp -30 556
222TM
N KD 151NmeGp1PsA
NmeGp1PsB
1476
D M10 N KD N KD 349
N KDN KD D yp -30 ADKADK
Nme7-like
Nm 5-lik
Spizellomyces punctatus
Mar. Drugs 2020, 18, x  5 of 23 
 
Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. umbers indicate amino acids. Proteins are represented in a scale 1:10 (1 
mm = 10 ami o acids). Protein domains have been indicated with colored boxes and e ch protei  has be n sea ched against SMART (Simple Modular Architecture 
Research T ol )/Pfa  data as . Abbreviations of do ai  names are retrieved from MART/Pfam databases and indic ted in the figure. Shortened names include: 
NDK, nucleoside diphosphate kinase; , adenylate kinase; Dpy-30, domain found in th  Dpy-30 proteins; DM10, uncharacterized domain; IQ, calmodulin-
binding m tif; TM, transmembrane region; omain which is not retrieved from SMART/Pfam database: MLS, mitochondrial localization signal according to [52]. 
 
Eukaryotic 
Supergroup Organis  
Nme Schematic Domain Presentatio
Group I Group II 
U
n i
k o
n t
s  
Opistokonts 
Homo sapiens 
 
 
Spizellomyces punctatu  
  
Apusozoa Thecamon s trahens 
 
 
Amoebozoa Dictyosteliu  purpureum 
 
 
B i
k o
n t
s  
R izaria Big lowiella natans 
 
 
Chromalveolata Phytophthora sojae 
  
177N KD
187N KDMLS
N KD 152
N KD 169
Nme1
Nme2
Nme3
Nme4
212
376
588
194
D yp -30N KD
N KDDM1
N KD N KDN KDThior doxin
N KD
Thioredoxin N KD 342
Nme5
Nme6
Nme7
Nme8
Nme9
SpB
SpA D 150
N KD 185
1423DThioredoxin
D M10 N KD N KD 382
N KD D yp -30 199Nme5-like
Nme7-like
Nme8-like N KD N KD N KD N KD N KD
154N KD
231N KD
N e p1TtA
NmeGp1TtB
Nme5-like
N KDD M10 N KD 427
D yp -30N KD
N KD
1316
183Nme6-like
Nme7-like
152N KDNmeGp1DpA
221N KDNmeGp1DpB
153N KDNme6-lik
145N KD
157N KD
NmeGp1BnA
312
N KD
N KD
234
meGp1BnB
NmeGp1BnC
NmeGp1BnD
Nme5-like ADKN KD D yp -30 556
222N KDTM
N KD 151NmeGp1PsA
NmeGp1PsB
1476
D M10 N KD N KD 349
N KDN KD D yp -30 ADKADK
Nme7-like
Nme5-like
Apusozoa Thecamonas trahens
Mar. Drugs 2020, 18, x  5 of 23 
 
Table 1. Sch matic arc itectu  of Nme proteins pr sent in eukaryotic representatives. Numb rs indicate mi o aci s. Proteins ar  represented in a s le 1:10 (1 
mm = 10 a ino acids). Protein domains have been i dicated with color d boxes and each protei  as be n searched agai st SMART (Simple Modular Architecture 
Research Tool )/Pfam databases. Abbreviations of domain names are retrieved from SMART/Pfam databases and indicated in the figure. Shortened names include: 
NDK, n cleoside diphosphate kinase; ADK, adenylate kinase; Dpy-30, domain found in th  py-30 roteins; DM10, uncharacterized domain; IQ, calmodulin-
binding motif; TM, transmembrane region; Domain which is not retrieved from SMART/Pfam database: MLS, mitochondrial localization signal according to [52]. 
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Table 1. Schematic architecture of Nme prot ins present in eukaryotic representatives. Number  i dicate amino acids. Prot ins are represented i  a scal  1:10 (1 
mm = 10 am no acids). Protein dom ins have b e  indicated with colore  box s and each protein has be n search d ag inst S ART (Simple Modular Architecture 
Research Tool )/Pfam databases. Abbreviations f domain names are retrieved from SMART/Pfa  databases and indicated in t e figure. Shortened names include: 
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Table 1. Schematic architecture of Nme proteins present in eukaryotic representatives. Numbers indicate amino acids. Proteins are represented in a scale 1:10 (1 
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Research Tool )/Pfa  database . Abbreviations of domain ames are ret iev d from SMART/Pfam databases and indicated in the figu . Shortened n mes include:
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Figure 1. Maximum likelihood phylogenetic trees illustrating relationship between NDK (A), ADK 
(B) and Dpy-30 (E) domains from Nme5-likeCc and protein domains from selected representatives. 
MCMC (Markov chain Monte Carlo) values are given below lines, bootstrap values above and 
accession numbers are given after protein names and species abbreviation. The scale bar indicates 
genetic distance of the branch lengths. Amino acid sequence alignments of ADK (C), Dpy-30 (F), and 
NDK (H) domains from representative species are accompanied with colored bars which show major 
motifs in these domains. Nine amino acid residues important for quaternary structure, nucleotide 
binding and catalysis are marked with asterisk. Homology modeling of the ADK (D), Dpy-30 (G), 
and NDK (I) sequences from Nme5-likeCc against the crystallographic algorithms of the human AK5 
(PDBID: 2BWJ), DPY30 (PDBID: 3G36) and Nme1 (PDBID: 3L7U), respectively. Shortened species 
names include Hs, Homo sapiens; Cc, Chondrus crispus; Tt, Thecamonas trahens; Dp, Dictyostelium 
purpureum; Am, Allomyces macrogynus; Df, Dictyostelium fasciculatum; Sp, Spizellomyces punctatus. 
Homology modeling of the ADK sequence from Nme5-likeCc against the crystallographic 
algorithms of the human AK5 (Protein Data Bank ID 2BWJ) demonstrated similar monomeric 
structures (Figure 1D). Human AK5 possesses Dpy-30 domain at the N-terminus, which may indicate 
Figure 1. Maximum likelihood phylogenetic trees illustrating relationship between NDK (A), ADK
(B) and Dpy-30 (E) domains from Nme5-likeCc and protein domains from selected representatives.
MCMC (Markov chain Monte Carlo) values are given below lines, bootstrap values above and accession
numbers are given after protein names and species abbreviation. The scale bar indicates genetic
distance of the branch lengths. Amino acid sequence alignments of ADK (C), Dpy-30 (F), and NDK (H)
domains from representative species are accompanied with colored bars which show major motifs in
these domains. Nine amino acid residues important for quaternary structure, nucleotide binding and
catalysis are marked with asterisk. Homology modeling of the ADK (D), Dpy-30 (G), and NDK (I)
sequences from Nme5-likeCc against the crystallographic algorithms of the human AK5 (PDBID: 2BWJ),
DPY30 (PDBID: 3G36) and Nme1 (PDBID: 3L7U), respectively. Shortened species names include Hs,
Homo sapiens; Cc, Chondrus crispus; Tt, Thecamonas trahens; Dp, Dictyostelium purpureum; Am, Allomyces
macrogynus; Df, Dictyostelium fasciculatum; Sp, Spizellomyces punctatus.
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Homology modeling of the ADK sequence from Nme5-likeCc against the crystallographic
algorithms of the human AK5 (Protein Data Bank ID 2BWJ) demonstrated similar monomeric
structures (Figure 1D). Human AK5 possesses Dpy-30 domain at the N-terminus, which may indicate
that recent human AK1/AK5 clade arose when ancestral three-domain Nme5-like split into Nme5 and
AK5. Phylogenetic analyses of the Dpy-30 domain support this thesis as Nme5-likeCc groups with
human AK5, rather than with any other human Dpy-30 protein (Figure 1E). Dpy-30 domain seems
to be well conserved, with hydrophobic residues and prolines present in all analyzed enzymes from
human and red algae (Figure 1F). The modeled Dpy-30 domain from the Nme5-likeCc is comprised of
a helix-loop-helix structure identical to the human Dpy-30 domain (Figure 1G). The two amino acid
deletion observed in the human Nme5 and the Nme5-likeCc sequence located in the α1 helix and three
amino acid insertion in the Kpn-loop (Figure 1H) cause significant structural changes in monomer
NDK structure, compared to Nme1 which may prevent hexamer assembly and/or enzymatic activity
(Figure 1I). However, the ATP binding cavity in the hexameric structure of Nme5-likeCc seems to be
much more conserved than it is the case in human Nme5 (Supplementary File Figure S1). Although,
NDPK domains are not significantly conserved (Supplementary File Table S1), Nme5-likeCc possesses
the NDK domain with all nine residues essential for ATP-binding, quaternary structure and catalysis,
unlike the inactive human Nme5 homologue. Therefore, we produced recombinant Nme5-likeCc to
test its activity.
2.2. The Ancestral Nme5-LikeCc Protein Forms a Multimer
Approximately 10 µg of soluble recombinant Nme5-likeCc protein was obtained from 1 L of
bacterial culture (Figure 2A). Most of the protein was insoluble and ended up in the pellet fraction. The
multimeric structure is required for the NDPK activity [14,56,57]. Eukaryotic Nme enzymes that belong
to Group I form trimers of parallel dimers forming an active hexamer. Dissociated subunits of these
Nme enzymes do not possess NDPK activity, although every monomer possesses one catalytic site [14].
Multimeric structure of any Group II Nme member is not yet determined or not even predicted,
although it is speculated that the trimeric association might be greatly altered in human Nme5, and it
is strongly in favor of a dimeric structure [24]. A high-molecular (>250 kDa) oligomeric structure was
found after cross-linking the Nme5-likeCc protein with glutaraldehyde. Previously described human
Nme1 was used as control (Figure 2B). The multimeric structure of Nme5-likeCc was also confirmed
by gel filtration (Figure 2C).
2.3. Recombinant Nme5-LikeCc Possesses NDPK Activity and Binds Nonspecifically to Various Types of DNA
The kinase activity of the recombinant Nme5-likeCc was quantified using a PK-LDH coupled
method that detects (d)ADP/(d)GDP as product of the phosphotransfer reaction between (d)ATP/(d)GTP
and dTDP nucleotides. The specific kinase activities of the Nme5-likeCc enzyme were measured and
found to be 273 ± 36 U/mg, 184 ± 14 U/mg and 225 ± 24 U/mg, when ATP, dATP and GTP were used
as phosphate donors, respectively. In comparison, the NDP kinase activity of Nme proteins ranged
from 208 U/mg to 2700 U/mg [58]. The specific activities of the Nme5-likeCc kinase were similar and
within the previously reported range for the human Nme1/2 protein. This protein is the first Group II
Nme family member with similar NDPK activity as the Group I Nme proteins. Interestingly, purified
recombinant Nme5-likeCc is devoid of detectable NDP kinase activity when dGTP was used as the
phosphate donor.
Nme proteins are able to bind nonspecifically and sequence-specific single-stranded linear/circular
DNA and/or double stranded DNA. For example, Nme2 is involved in DNA structural changes
necessary for the activity of the c-myc promoter [59]. To test binding activities, Nme5-likeCc protein
was incubated with various types of DNA; single-stranded circular DNA from the bacteriophage
ϕX174, double-stranded circular DNA (bacteriophage ϕX174 RF I), double-stranded 57-bp nuclease
hypersensitive element of the c-myc promoter and single-stranded telomeric DNA (TTAGGG)6. The
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recombinant protein displayed the ability to bind to all tested DNA types, showing the DNA band
retardation effect (Figure 3).Mar. Drugs 2020, 18, x  9 of 22 
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purified with cobalt-charged agarose column—TALON (T), concentrated and desalted using Ultracel
(U) was blotted against anti-His antibody (1:5000) and visualized using chemiluminescence detection.
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Figure 3. DNA-binding activity of the Nme5-likeCc protein. The reaction was performed in buffer
containing 100 mM KCl, 10 mM MgCl2, 50 mM Tris HCl pH 7.5, 0.2 mM DTT, 10 µg/mL BSA and (A)
10 ng of single-stranded circular DNA or (B) 10 ng of double-stranded circular DNA or (C) 30 ng of
single-stranded 36-bp DNA or (D) 30 ng of double-stranded 57-bp DNA and purified Nme5-likeCc
protein as indicated. BSA was used as control. Products were analyzed in 1% agarose gel (A,B) or 4%
agarose gel (C,D) and stained with SYBR gold. Notice that protein-DNA complex remain trapped in
the wells at 2 and 3.5 µg protein amounts.
2.4. The Ancestral Nme5-LikeCc Protein Localizes in Nucleus and Cytoplasm
Nme enzymes are mainly cytoplasmic, but can be found, at least transiently, associated with
membranous structures and in the nuclei [15]. Several of them (Nme3, Nme4 and Nme6) localize in
mitochondria, at least partly. Nme4 possesses the canonical mitochondrial signaling sequence and
exclusively localizes in this organelle [52,60]. Human Nme7 was recently identified as a centrosomal
protein [23], while Nme5 was found to be microtubule associated [25]. We transiently transfected HeLa
and HEK293T cells with GFP-Nme5-likeCc and analyzed the cells 48 h post transfection using confocal
laser scanning microscopy (Figure 4). Since ancestral Nme5-likeCc seems to have characteristics of
an active Nme enzyme, unlike the recent human homologue Nme5, we investigated its localization
in comparison to other active NME members, namely Nme1. Human Nme1 is mainly localized in
the cytoplasm and to a lesser extent in the nucleus of HEK293T, which is consistent with a previous
study [61]. Protein GFP-Nme5-likeCc is dispersed throughout the cytoplasm rather than associated
with a specific organelle. The overlay (yellow signal) indicates colocalization of the human Nme1 and
Nme5-likeCc in the cytoplasm. A more pronounced nuclear localization for the GFP-Nme5-likeCc in
HEK293T cells can be seen very clearly (Figure 4).
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Figure 4. Subcellular localization of Nme5-likeCc. HeLa and HEK293T cells were transiently transfected
with pEGFP-Nme5-likeCc (green fluorescence), pCherry-Nme1Hs (red fluorescence), pECFP-Golgi
(cyan) and pECFP-mitochondria (cyan). The overlay (yellow) indicates colocalization of the human
Nme1 and Nme5-likeCc. Scale bar = 10 µm.
2.5. The Ancestral Nme5-LikeCc Protein Diminished Colony Growth in HEK293T Cell Line and Inhibited
Cell Proliferation
It has been demonstrated that the human Nme1 suppresses anchorage independent growth in
soft agar in human breast adenocarcinoma cell lines MDA-MB-435 and MDA-MB-231. Moreover,
Nme2, Nme4 and Nme5 significantly diminished colony growth in both cell lines [61]. Another
study showed that stably-transfected chronic myeloid leukemia K562 cells, expressing RNAi for
post-transcriptional silencing of Nme1 gene, exhibited a markedly increased ability to form colonies in
terms of number and size compared to the control [62]. Furthermore, it has been established that the
murine neuroblastoma cell line N1E-115 expressing Nme3 formed significantly fewer colonies in soft
agar [63], while both Nme2-expressing NIH3T3 fibroblasts and Nme2-expressing HLK3 hepatocytes
form colonies, unlike control cells that do not form any [64]. Compared to control, stable transfectants of
human neuroblastoma NB69 cell lines expressing Nme1 and mutant Nme1S120G form 2.8 and 3.6 times
more colonies on soft agar, respectively, indicating that Nme1 aberrations provide neuroblastoma cells
with additional in vitro colonization ability [65]. Since Nme family members seem to have an impact
on soft agar colony forming in various cell types, we tested Nme5-likeCc prospective suppression.
In comparison to control cells, the transfected HEK293T cells exhibited decreased ability to form
colonies on soft agar by 1.8-fold (p = 2.69 × 10−6) (Figure 5A). The colonies formed by the Nme5-likeCc
HEK293T cells were significantly smaller, (the largest were composed of 25 cells) compared to the
colonies formed by the control empty vector (mostly >40 cells). Colonies with more than 20 cells were
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counted. Further, we analyzed the effect of Nme5-likeCc on cell proliferation. The growth rate of cells
was evaluated at different time points after transfection, to determine whether the overexpression of
Nme5-likeCc affects cell proliferation (Figure 5B). The pcDNA3 ”empty” vector was used as control. The
transfection markedly increased Flag-Nme5-likeCc levels (Figure 5C). Subsequently, the proliferation
of pcDNA3-Nme5-likeCc-transfected HEK293T cells decreased 1.83-fold (p = 0.0004) comparing to
cells with pcDNA3 control (Figure 5B). The cell viability decreased by 45.4% 72 h post-transfection
compared to cells possessing the control vector. The results presented in Figure 5B demonstrate that
while the Nme5-likeCc inhibits proliferation of HEK293T cells tested at 48 h and 72 h post-treatment, it
enhances cell proliferation 1.46-fold (p = 0.005) when compared to cells with pcDNA3 control 24 h
post-transfection. The results of these assays show that the Nme5-likeCc modulates cell proliferation
in the HEK293T cell line.Mar. Drugs 2020, 18, x  13 of 22 
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Figure 5. (A) Quantitative results of soft agar colonization assay with HEK293T cells transfected with
pcDNA3-Nme5-likeCc or empty vector pcDNA3 (B) The relative growth rates assessed by CellTiter-Glo
assay of HEK293T cells transfected with pcDNA3-Nme5-likeCc or empty vector pcDNA3 and protein
blot validation of Flag-Nme5-likeCc expression (C). Data are representative of three independent
experiments (* p < 0.05).
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3. Discussion
Distribution analyses indicate that the ancestor of all eukaryotes probably possessed two Group
II members of Nme family of proteins, namely Nme5-like and Nme7-like. The domain organization
of Nme5-like protein from red algae C. crispus probably reflects the structure of the ancestral protein
(Figure 6). Phylogenetic analyses revealed that the C-terminal end of Nme5-likeCc is most similar to
recent metazoan AK5 protein. We propose a hypothesis that the ancestral gene split in two genes very
early in the eukaryotic evolution but remained conserved in several basal eukaryotic representatives.
The human AK5 is cytosolic, or both nuclear and cytosolic [66] expressed almost exclusively in the brain,
the pons and the spinal cord. This active kinase phosphorylates AMP, dAMP, CMP, and dCMP using
ATP or GTP as phosphate donors [67]. Interestingly, it can also use ATP and GTP to phosphorylate
CDP, GDP, UDP, dADP, dCDP, dGDP, and TDP and, like many other adenylate kinases, acts like an
NDP kinase [68]. The adenylate kinase complements NDPK function in the ndk-disrupted strains of
Escherichia coli [69]. The NDP kinase is absent in Ureaplasma parvum genome, but U. parvum possesses
five nucleoside monophosphate kinases (NMPKs): adenylate kinase (ADK), cytidylate kinase (CMPK),
uridylate kinase (UMPK), guanylate kinase (GMPK), and thymidylate kinase (TMPK). ADK, CMPK,
UMPK, and TMPK from Ureaplasma were purified and characterized and it was discovered that these
NMPKs are base specific and are capable of converting (d)NMPs directly to (d)NTPs [70]. These
intriguing connections between ADK and NDPK enzymes can be further elucidated by the analyses of
the ancestral Nme5-likeCc protein. Future site-directed mutational studies should explain whether its
NDPK activity is due to the active ADK domain and if the NDK domain lost its NDPK activity very
early in the evolution of eukaryotes. The crystal structure of this multimeric enzyme should reveal
interactions between NDK and ADK domains that are essential for its activity and confirm if these
interactions still exist, even after the ancestral gene split (e.g., interactions between human Nme5 and
AK5). Our analyses showed that Nme5-likeCc protein can bind to various types of DNA. It can bind to
single-stranded telomeric DNA (TTAGGG)6, to the double-stranded 57-bp nuclease hypersensitive
element of the c-myc promoter, and also to the single-stranded circular DNA from bacteriophage φX174
like human Nme2 [53,59,71]. It is yet to be determined whether this affinity to various types of DNA
is sequence specific. Nonspecific DNA binding by Nme5-likeCc is not incompatible with potential
sequence-specific DNA-binding because, for example, human transcription factor Nme2 also binds the
DNA sequence nonspecifically, particularly when the substrate DNA is single-stranded [72]. It should
also be elucidated if the more pronounced nuclear localization of the EGFP-Nme5-likeCc in HEK293T
cells is associated with its potential transcriptional or some other nuclear activity.
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Glu-132). In human inactive Nme5, Leu-94 and Asn-100 replace Arg and Thr residues, respectively
which are involved in the interaction with the β-phosphate and the maintenance of the quaternary
structure [24]. It was also shown that Ser-120 and Pro-96 in Nme1 protein are important for hexameric
oligomerization [73]. The serine (Ser-123) residue is conserved in Nme5-likeCc. The insertion of three
amino acids in the Kpn-loop present in the human Nme5 is evident in the ancestral Nme5-likeCc, as
well. This insertion is located near Pro-96 (Nme1). Thus, we can conclude that although all the residues
necessary for the hexameric structure are present in Nme5-likeCc enzyme, and known residues that
could impede this structure are absent, the insertion of three amino acids seems to have an impact on
the multimeric structure of Nme5-likeCc. However, the multimeric formation of the Nme enzyme
that exceeds conjugation of more than six monomers has not yet been described. Adenylate kinase
enzymes can form both dimers and higher supramolecular structures [74,75]. The crystal structure of
the adenylate kinase from maize revealed that the enzyme can form rods that are linear assemblies
of hexamers. It was proposed that the supramolecular assembly into rods occur in vivo overnight in
mesophyll chloroplasts. Presumably rods represent a natural inactive storage form that assembles at
night when maize stops CO2 assimilation, i.e., most of the AMP production via C4 cycle [75]. This
supramolecular assembly might have originated very early in plant evolution and might also be
connected to a C4-like carbon-fixation pathway that might be present in red algae. Most of the essential
genes related to the C4-pathway are present in red algae and special C4-like carbon-fixation pathway
might play an important role in the conchocelis stage of Rhodophyta [76,77]. It is yet to be determined
if the supramolecular assembly of the Nme5-likeCc is characteristic for particular developmental stage
during the life cycle of C. crispus.
Our results show that besides the role in the maintenance of the cellular NTP pool, Nme5-likeCc
probably has an impact on cell proliferation. It was suggested that NF-κB is a key executor of human
Nme5 in regulating apoptosis and the cell cycle. Human Nme5 was capable of binding NF-κB p65 and
affecting its expression level, suggesting that Nme5 probably acted upstream of NF-κB p65 pathway.
However, the overexpression of Nme5-likeCc did not induce apoptosis (data not shown) in HEK293T
cells, which may suggest that the mechanism underlying this effect was established later in metazoan
evolution. These results support the idea that the algal protein has a different cellular function in
comparison to its human homolog. Therefore, we conclude that the structure of the ancestral Nme5
gene has changed during metazoan evolution, possibly in correlation with the function of the protein.
4. Materials and Methods
4.1. Distribution of the Nme Protein Family Across Eukaryotic Supergroups and Phylogenetic Analyses
Eukaryotic Nme proteins from model organisms with fully sequenced genomes were obtained from
the NCBI non-redundant (NR) database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Additionally, BLASTP
on the Ensembl database (http://www.ensembl.org/index.html) were used. Genomes were also searched
at the http://www.broadinstitute.org/annotation/genome/multicellularity_project/GenomesIndex.html.
Domain architectures of retrieved sequences were obtained from the databases Pfam (http://www.
sanger.ac.uk/Software/Pfam) and SMART (http://smart.embl.de/) and examined through the NCBI
conserved domain search website (http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). The 3D
structures of the ADK, Dpy-30, and NDK domains were modeled by homology-modeling using
SWISS-MODEL (http://swissmodel.expasy.org//SWISS-MODEL.html) and molecular presentations
were generated using the PyMOL program (http://www.pymol.org).
The collected amino acid sequences were aligned with MUSCLE (Multiple Sequence Comparison
by Log- Expectation) multiple alignment tool, using default settings [78]. The multiple alignment
was subjected to maximum-likelihood (ML) analysis using MEGA6 (Molecular Evolutionary Genetics
Analysis) [79], while the Bayesian MCMC analysis was conducted in MrBayes 3.1.2 [80]. The model
for the ML analysis was selected with ProtTest 2.4 and the Akaike information criterion (AIC) [81],
which indicated a Le_Gascuel model (I+G) [82]. Bootstrap tests were performed with 1000 replicates.
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4.2. Isolation of Genomic DNA from Chondrus Crispus and Nme5-Like Gene Cloning
The genomic DNA from the red alga, C. crispus (Gigartinales, Rhodophyta) was extracted using
DNeasy Plant Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer’s protocols, with
the following modifications: 100 mg of frozen tissue was ground in liquid nitrogen and resuspended in
800 µL of lysis buffer. Samples were vigorously vortexed for several minutes and incubated for 30 min
at 65 ◦C with shaking. A centrifugation step was added to remove potential clumps. Approximately
5 µg of DNA was obtained from 100 mg of tissue powder.
For the overproduction of recombinant Nme5-likeCc protein 5′-CTGCACATATGGTCGGC
CTGCAAATCGAG-3′ and 5′-ATATGGATCCTTTTAAAAAAGGCCGATCAC-3′ set of primers were
used to amplify Nme5-likeCc. PCR product and pET-15b expression vector were ligated after
NdeI/BamHI restriction.
For the localization assay, Nme5-likeCc was cloned in fusion with EGFP into pEGFP-C1
(XhoI/BamHI restriction sites) using the following set of primers: 5′-CCCACTCGAGCTATGGTCGGCC
TGCAAATCG-3′ and 5′-ATATGGATCCTTTTAAAAAAGGCCGATCAC-3′.
For cell proliferation, apoptosis, and soft agar colonization, assay mammalian expression vector
pcDNA3 was used to clone Nme5-likeCc into BamHI/EcoRI restriction sites using the following set
of primers: 5′-CTAGGGATCCACGAGATGGACTACAAGGACGACGACGATAAGATGGTCGGC
CTGCAAATC-3′ and 5′-GAATATGAATTCTTTTAAAAAAGGCCGATCAC-3′.
All PCR reactions were performed using Q5 High-Fidelity DNA Polymerase (NEB). Plasmid
constructs were verified by sequencing (ABI PRISM 3100-Avant Genetic Analyzer, Applied Biosystems,
Foster City, CA, USA) using ABI PRISM BigDye Terminator v.3.1 Ready Reaction Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA, USA).
4.3. Expression and Purification of the Recombinant Nme5-LikeCc Protein and Western Analyses
The soluble recombinant His-Nme5-likeCc protein, visible after SDS-PAGE, was obtained under
the following growth conditions: Escherichia coli strain BL21(DE3) harboring the plasmid was grown
to OD600 1.2 and protein expression was induced with 0.05 mM IPTG for 1 h at 30 ◦C. Bacteria were
collected by centrifugation, resuspended in lysis buffer (50 mM Tris HCl, 300 mM NaCl, 10 mM
imidazole, and 1 mg/mL lysozyme), incubated 30 min on ice and sonicated 8× 30 sec (50% of full power).
After 25 min of centrifugation (12,000 rpm) at 4 ◦C, the supernatant was applied onto cobalt-charged
agarose column (TALON). Histidine tagged proteins was eluted with 300 mM imidazole. Collected
eluates were separated by SDS-PAGE (Bio-Rad, Hercules, CA, USA) and electrotransfered onto PVDF
Hybond-P membrane (Amersham Biosciences, Buckinghamshire, United Kingdom). For the detection
of His-Nme5-likeCc, the membranes were incubated with anti-His antibody (Amersham Biosciences,
Buckinghamshire, United Kingdom). Protein bands were visualized using chemiluminescence detection
(Amersham ECL Plus, GE Healthcare Chicago, IL, USA). Nme5-likeCc protein was concentrated and
desalted using Amicon Ultra 10K device (Millipore, Burlington, MA, USA). The same Ultracel was
used for buffer exchange (Nme buffer, [53]).
4.4. Oligomerization of Protein and Gel Filtration Chromatography
The oligomerization of the recombinant Nme5-likeCc protein was performed in PBS buffer as
follows: 300 ng of protein were pre-incubated in PBS at room temperature and various concentrations
of glutaraldehyde were added to initiate the cross-linking. Following 15 min incubation, the reaction
was quenched with 0.2 M Tris-HCl, pH 7.5, for 15 min at room temperature. The reaction product was
subjected to 12% SDS-PAGE, transferred onto PVDF Hybond-P membrane (Amersham Biosciences,
Buckinghamshire, United Kingdom) and visualized as described before. Human Nme2 protein was
used as a control.
Gel filtration chromatography using the fast protein liquid chromatography (FPLC) system was
employed for the determination of the protein MW. Recombinant Nme5-likeCc was loaded onto
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HiLoad 26/600 Superdex 200 prep grade column and eluted with Nme buffer [53] at a flow rate of
1 mL/min. The standard protein markers for gel filtration chromatography were as follows: ferritin
(440 kDa), β-amylase (200 kD) and alcohol dehydrogenase (150 kD).
4.5. NDP Kinase Assay
NDPK activity was measured using a coupled pyruvate kinase—Lactate dehydrogenase (PK-LDH)
assay [83,84] in the presence of various phosphate donors (ATP, dATP, GTP, and dGTP) and dTDP as
phosphate acceptors. Reaction mixtures comprised 50 mM Tris-HCl pH 7.4, 75 mM KCl, 5 mM MgCl2,
and 1 mM phosphoenolpyruvate, 0.1 mg/mL NADH, 1 mM (d)NTP, 0.2 mM dTDP, 2 U/mL of PK
(from rabbit muscle, SIGMA, St. Louis, MO, USA), 2.5 U/mL of LDH (from rabbit muscle, SIGMA, St.
Louis, MO, USA) and 1 mg/mL BSA. Reactions were initiated by the addition of 50 ng of Nme5-likeCc
enzyme and the activity was monitored in an Ultrospec 2100 pro (Amersham Pharmacia Biotech,
Amersham, Buckinghamshire, United Kingdom) by measuring the decrease in absorbance at 340 nm.
All reactions were performed in triplicate. Results are presented as an average of three measurements
± standard deviations.
4.6. DNA-Binding Assay
The affinity of recombinant Nme5-likeCc to various types of DNA was tested in vitro. Reactions
contained 10 ng of single-stranded circular DNA from bacteriophage ϕX174 (NEB) and 10 ng
of double-stranded circular DNA (bacteriophage ϕX174 RF I (NEB)). The amount of purified
protein is indicated (Figure 2). BSA was used as a control. The reaction mixture was incubated
in 20 µL of buffer containing 100 mM KCl, 10 mM MgCl2, 50 mM Tris HCl pH 7.5, 0.2 mM
DTT, 10 µg/mL BSA. After 45 min of incubation at 37 ◦C, products were subjected to gel
electrophoresis in 1% agarose and stained with SYBR gold (Invitrogen). Thirty nanograms of
double-stranded 57-bp nuclease hypersensitive element of the c-myc promoter (5′-GATCCCCAGT
CTCCTCCCCACCTTCCCCACCCTCCCCACCCTCCCCATAAGCGAATT-3′), as well as 30 ng of
single-stranded telomeric DNA (TTAGGG)6 were incubated with recombinant protein in the same
reaction buffer. After 30 min of incubation at 37 ◦C, products were subjected to gel electrophoresis in
4% agarose and stained with SYBR gold (Invitrogen, Carlsbad, CA, USA).
4.7. Transient Transfections and Laser Scanning Confocal Microscopy
HeLa and HEK293T cells were used for transfection by Lipofectamine 3000 reagent (Invitrogen),
according to the manufacturer’s instructions. Twenty-four hours prior to transfection, 5 × 104 cells
were seeded onto 24-well culture slides containing DMEM supplemented with 10% FBS and grown
until 80% confluent. Cells were transfected with 500 ng of plasmid DNA. Forty-eight hours post
transfection, the cells were washed with PBS pH 7.5, fixed in 4% formaldehyde, and mounted in
SlowFade Diamond Antifade Mountant, with or without DAPI (Molecular Probes, Eugene, OR, USA).
Fluorescent images were obtained using a Leica SP8 X FLIM laser scanning confocal microscope
(Leica Microsystems, Wetzlar, Germany) equipped with HC PL APO CS2 63×/1.40 OIL objective. GFP
was excited by 488 nm, CFP using 433 nm, and DAPI using 405 nm laser lines.
4.8. Soft Agar Colonization Assay
HEK293T cells were transfected as described above with FLAG-Nme5-likeCc or empty pcDNA3
expression vector in triplicate. Forty-eight hours post-transfection cells were suspended in 1 mL 10%
FBS DMEM, containing 0.36% agar and layered on a 0.75% agar in a 6-well plate at a concentration of
5 × 103 cells/well. Cells were incubated for 16 days at 37 ◦C and 5% CO2. Colonies were stained with
0.005% Crystal Violet and counted.
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4.9. Cell Proliferation Assay
Cells were transfected as described above, trypsinized 24 h post-transfection, and 103 viable cells
suspended in 90 µL 10% FBS DMEM were added to each well of 96-well plates. Cell proliferation
was measured using CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, Wisconsin,
United States) according to the manufacturer’s instructions with luminometer Infinite 200 (TECAN,
Männedorf, Switzerland). The concentration of ATP was measured in triplicate, and error bars
represent the 95% confidence interval. The expression of FLAG-Nme5-likeCc was checked by Western
blot analyses with anti-FLAG M2 antibody (1:5000) (Sigma-Aldrich, St. Louis, MO, USA).
4.10. Detection of Apoptosis
Cells were transfected as described above, trypsinized 24 h post-transfection, and 5 × 103 viable
cells suspended in 100 µL 10% FBS DMEM were seeded in 96-well culture plates. Caspase-3/7 activity
was measured using the Caspase-Glo 3/7 Assay Kit (Promega, Madison, Wisconsin, United States)
according to the manufacturer’s instructions with luminometer Infinite 200 (TECAN, Männedorf,
Switzerland).
4.11. Statistical Analyses
Statistical analysis was performed using Student’s t-test. Probabilities of less than 0.05 were
considered statistically significant.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/1/13/s1,
Figure S1: Crystal structure of human nucleoside diphosphate kinase A S120G complexed with ADP (PDBID:
2HVE1) (orange, A), overlaid with human Nme5 (green, B) or Nme5-likeCc (white, C). Arrows indicate the
ADP-binding cavity. Note disturbances produced by 3 aa insertion in Kpn loop in human Nme5 indicated
by yellow arrows, Table S1: The percentage of identical amino acids and overall sequence similarity between
NDPK domains.
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